| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |